Roche adjusted 1H profit declines 24%, sales up 6%

LONDON (CBS.MW) -- Swiss pharmaceutical Roche Group on Wednesday posted a 24 percent decline in first half net income on an adjusted basis to SFr1.585 billion, while sales rose 6 percent to SFr13.88 billion. It noted that net income was affected by a one-time gain in the year-earlier period on the sale of LabCorp shares. Sales in its pharmaceutical division increased 9 percent, or 21 percent in local currency, to SFr10.3 billion and diagnostics division sales eased 1 percent, or increased 7 percent on constant currency terms, to SFr3.56 billion. It reiterated its full-year guidance of both sales and operating profit to increase by double-digits in local currencies.

Have breaking news sent to your inbox. Subscribe to MarketWatch's free Bulletin emails. Sign up here.

Intraday Data provided by SIX Financial Information and subject to terms of use. Historical and current end-of-day data provided by SIX Financial Information. All quotes are in local exchange time. Real-time last sale data for U.S. stock quotes reflect trades reported through Nasdaq only. Intraday data delayed at least 15 minutes or per exchange requirements.